Biotech | August 16, 2022
PharmaCyte Biotech reaches cooperation agreement with Iroquois Capital
Company appoints five new independent directors to reconstituted board
Company appoints five new independent directors to reconstituted board
The hospital will use the bus to reach out to people with eye ailments through their various eye camps, diagnosing and treating them wherever possible.
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
A new market study published by Global Industry Analysts (GIA), released its report titled, ``Healthcare Supply Chain Management—Global Market Trajectory & Analytics.’’ We present excerpts from the report
By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas
Biocon Ltd, an innovation-led global biopharmaceuticals company, has announced that the Board of its subsidiary Biocon Biologics Ltd has approved a primary equity investment of US $75 million (Rs. 555 crores) by Abu Dhabi based ADQ, one of the region’s largest holding companies.
Roche also shared the design of its upcoming Phase III TRONTIER 1 and 2 trials investigating trontinemab in people with early symptomatic Alzheimer’s disease
The company would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Subscribe To Our Newsletter & Stay Updated
